Navigation Links
Immunomedics Reports Initial Clinical Results With Hpam4 For,Pancreatic Cancer Therapy

ll clinical trials evaluating epratuzumab for the treatment of patients with moderate and severe lupus. At present, there is no cure for lupus and no new lupus drug has been approved in the U.S. in the last 40 years. The Company is conducting clinical trials with hA20 in patients with non-Hodgkin's lymphoma, epratuzumab as a potential therapeutic for patients with lymphoma and leukemia, 90Y-epratuzumab for the therapy of patients with lymphoma, 90Y-hPAM4 for pancreas cancer therapy and hCD74 as a therapy for patients with multiple myeloma. We believe that our portfolio of intellectual property, which includes approximately 108 patents issued in the United States, and more than 250 other issued patents worldwide, protects our product candidates and technologies. We also have a majority ownership in IBC Pharmaceuticals, Inc., which is developing a novel Dock and Lock (DNL) methodology, and a new method of delivering imaging and therapeutic agents selectively to disease, especially different solid cancers (colorectal, lung, pancreas, etc.), by proprietary, antibody-based, pretargeting methods. For additional information on us, please visit our web site at http://www.immunomedics.com. The information on our website does not, however, form a part of this press release.

This release, in addition to historical information, may contain forward- looking statements made pursuant to the Private Securities Litigation Reform Act of 1995. Such statements, including statements regarding clinical trials, out-licensing arrangements (including the timing and amount of contingent payments), forecasts of future operating results, and capital raising activities, involve significant risks and uncertainties and actual results could differ materially from those expressed or implied herein. Factors that could cause such differences include, but are not limited to, risks associated with new product development (including clin
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
2. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
3. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
4. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
5. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
6. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
7. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
8. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
9. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
10. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
11. Affymax Reports Phase 2 Clinical Dose Ranging Results of Once-Per-Month Hematide for the Treatment of Anemia
Post Your Comments:
(Date:3/4/2015)... , Deutschland, 4. März 2015 /PRNewswire/ ... Anbieter von medizinischen Bildmanagementlösungen für Unternehmen, baut ... von Randolph Sternberg zum Director of Sales ... of Operations weiter aus. Logo ... Randolph Sternberg ist für den Verkauf ...
(Date:3/4/2015)... 4, 2015 Oramed Pharmaceuticals Inc. ... clinical-stage pharmaceutical company focused on the development of oral ... participate in the upcoming 27 th Annual ROTH ... Dana Point, CA.  Dr. Michael Berelowitz ... will present a corporate overview on March 10, 2015. ...
(Date:3/4/2015)... 2015 Perrigo Company plc (NYSE: PRGO ... Joseph C. Papa will present at the 2015 ... 11, 2015 at the Loews Miami Beach Hotel in ... presentation webcast at http://perrigo.investorroom.com/events-webcasts . From its ... Perrigo Company plc, headquartered in Ireland , ...
Breaking Medicine Technology:TeraRecon baut seine Präsenz in EMEA aus 2TeraRecon baut seine Präsenz in EMEA aus 3Oramed to Present at the ROTH Conference 2Oramed to Present at the ROTH Conference 3Perrigo Company To Present At The 2015 Barclays Global Healthcare Conference 2
... /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NASDAQ: SVA ), ... its unaudited second quarter financial results for the period ended ... Highlights Sales increased 52.5% year-over-year to $15.7 ... shareholder reached $1.32 million and EPS was $0.02 per share. ...
... Corporation (NYSE: SHP ) ("ShangPharma" or the ... development outsourcing company, today announced that its Board of ... expects to use cash and internally generated funds to ... The board has authorized ShangPharma to buy up ...
Cached Medicine Technology:Sinovac Reports Unaudited Second Quarter 2011 Financial Results 2Sinovac Reports Unaudited Second Quarter 2011 Financial Results 3Sinovac Reports Unaudited Second Quarter 2011 Financial Results 4Sinovac Reports Unaudited Second Quarter 2011 Financial Results 5Sinovac Reports Unaudited Second Quarter 2011 Financial Results 6Sinovac Reports Unaudited Second Quarter 2011 Financial Results 7Sinovac Reports Unaudited Second Quarter 2011 Financial Results 8Sinovac Reports Unaudited Second Quarter 2011 Financial Results 9Sinovac Reports Unaudited Second Quarter 2011 Financial Results 10Sinovac Reports Unaudited Second Quarter 2011 Financial Results 11Sinovac Reports Unaudited Second Quarter 2011 Financial Results 12Sinovac Reports Unaudited Second Quarter 2011 Financial Results 13Sinovac Reports Unaudited Second Quarter 2011 Financial Results 14ShangPharma Announces Up to $10 Million Share Repurchase Program 2
(Date:3/4/2015)... 2015 Nitrosigine®, a patented complex of ... sports nutrition products, is hosting the Nitrosigine Pump Challenge ... Terrace Ballroom at The Arnold Sports Festival in Columbus, ... to March 8, 2015. , Nitrosigine is a ... Dietary Ingredient notification status; now affirmed as GRAS.^ It ...
(Date:3/4/2015)... March 04, 2015 The report “Vasculitis ... the therapeutic development for Vasculitis. Vasculitis is a disease ... cause of vasculitis diseases is not known. Vasculitis can ... range of symptoms. Symptoms can include fever, weight loss, ... a pulse in a limb. Vasculitis is treatable, but ...
(Date:3/4/2015)... The week of March 2nd - 8th ... Awareness Day being recognized on March 13th, the aim ... risks associated with sleep related illnesses, costing the United ... of America have turned to social media with an ... virally inspire conversation regarding the disease. , The ...
(Date:3/4/2015)... March 04, 2015 Follow us ... public health issue worldwide. The rising prevalence of high ... social burden in both developed and developing countries. By ... to rise to 1.5 billion, equating to approximately 30% ... patients are forecast to come from the developing countries. ...
(Date:3/4/2015)... March 04, 2015 Bird B Gone, ... and residential applications now offers its popular plastic (polycarbonate) ... humane, highly efficient bird deterrent is ready-to-use ... the color and décor of the building or structure ... red, white, crystal clear, light grey, brown, black and ...
Breaking Medicine News(10 mins):Health News:Nitrosigine® Challenges Fitness Enthusiasts at The Arnold to Get Pumped 2Health News:Nitrosigine® Challenges Fitness Enthusiasts at The Arnold to Get Pumped 3Health News:Vasculitis Therapeutics Pipeline H1 2015 Review Report Available at RnRMarketResearch.com 2Health News:Vasculitis Therapeutics Pipeline H1 2015 Review Report Available at RnRMarketResearch.com 3Health News:Vasculitis Therapeutics Pipeline H1 2015 Review Report Available at RnRMarketResearch.com 4Health News:Innovative Sleep Apnea Procedure Could Save US Healthcare System Billions 2Health News:Innovative Sleep Apnea Procedure Could Save US Healthcare System Billions 3Health News:Innovative Sleep Apnea Procedure Could Save US Healthcare System Billions 4Health News:Aging Population Drives Demand for Blood Pressure Monitoring & Measurement Instruments, According to a New Report by Global Industry Analysts, Inc. 2Health News:Aging Population Drives Demand for Blood Pressure Monitoring & Measurement Instruments, According to a New Report by Global Industry Analysts, Inc. 3Health News:Aging Population Drives Demand for Blood Pressure Monitoring & Measurement Instruments, According to a New Report by Global Industry Analysts, Inc. 4Health News:Plastic Bird Spikes Now Come in 7 Colors to Blend in With Their Surroundings 2
... Your ability to listen to a phone message in ... other earand comprehend what both are sayingis an ... say researchers of the National Institute on Deafness and ... of Health. ,The finding, published in the ...
... Believe it or not, Kapila, an impregnated cow of Sarnagat ... the age of two without ever getting crossed with a ... years now. ,According to the cows owner Sardar ... two-years-old and that too without ever getting pregnant. ...
... a new review of studies,School-based sexual abuse prevention programs ... increase self-protective behaviors. ,However, the programs have ... fearful of strangers, the review cautions. ,,It was ... found in the review, but we were pleased that ...
... dig into that apple or lentils, for a new study ... slowly once they have been consumed helps dieters lose more ... ,Foods that release sugars rapidly are said to ... slowly have a low glycaemic index, and Cochrane researchers led ...
... The Balehonnur-based Central Coffee Research Institute (CCRI) has said that ... market in December 2007 . ,After 21 years ... on December 15. The yet-to-be named hybrid, hi-yielding arabica variety ... less resistant to the widely prevalent white stem borer. ...
... universal influenza vaccine that has been pioneered by researchers ... the first time on humans by the British-American biotech ... intended to provide protection against all A strains of ... ,In the 1990s, VIB researchers connected ...
Cached Medicine News:Health News:Genes Influence the Ability to Listen Two Things at a Time 2Health News:Genes Influence the Ability to Listen Two Things at a Time 3Health News:School-based Sexual Abuse Prevention Programs 2Health News:School-based Sexual Abuse Prevention Programs 3Health News:Apples and Lentils Could Help You to Shed Off Those Extra Pounds! 2Health News:Human Trial for Universal Influenza Vaccine Underway 2
... is a reagent and probe system used ... high throughput plate based system is a ... a unique approach for RNA detection and ... branched DNA (bDNA) technology. Branched DNA allows ...
QC 123 is an assayed quality control material for blood gas instrumentation. It is available in three (3) levels for monitoring analyzer performance at varying points within the clinical range....
For the qualitative detection of Wuchereria bancrofti antigen in whole blood, serum and plasma specimens...
For the qualitative detection of Hepatitis B surface Antigen (HBsAG) in human serum, plasma and whole blood specimens...
Medicine Products: